Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −34,443−100.0% | Sold out | Holders |
| Q2 2024 | 34,443 | $4.74M | <0.1% | −356,801−91.2% | Reduced | Holders |
| Q1 2024 | 391,244 | $54.0M | 0.2% | +344,263+732.8% | Added | Holders |
| Q4 2023 | 46,981 | $6.19M | <0.1% | +46,981 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −2,598−100.0% | Sold out | Holders |
| Q4 2022 | 2,598 | $311.0K | <0.1% | +2,598 | New | Holders |